Portnoy Law Firm Announces Class Action on Behalf of Cytokinetics, Incorporated Investors
(NASDAQ:CYTK), LOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Cytokinetics, Incorporated, (“Cytokinetics” or the “Company”) (NASDAQ: CYTK) investors of a class action on behalf of investors that bought securities between December 27, 2023 and May 6, 2025, inclusive (the “Class Period”). Cytokinetics investors have until November 17, 2025 to file […]